What this post covers: Where GLP-1 receptors sit in the brain and why that matters for reward and compulsion The clinical trial pipeline for GLP-1 agonists in addiction (alcohol, nicotine, opioids) Why anhedonia may be a dosing problem, not a drug problem, and the ziprasidone parallel Real-world observations from low-dose tirzepatide combined with ketogenic diets The scope-of-practice question: should psychiatrists be prescribing GLP-1 agonists
NauckMANiedereichholzUEttlerRHolstJJrskovCRitzelRet al
Edgerton DS, Cardin S, Pan C, et al
Dragon Peptide BPC-157 is typically administered subcutaneously (under the skin) or intramuscularly (into the muscle)
Exenatide is eliminated primarily through the kidneys, and its use is not recommended in patients with a creatinine clearance (CrCl) of 30 mL/min
Try to lift some weights or work with resistance bands, starting with two to three times a week